CA
AXNX

CastleArk Alternatives’s Axonics, Inc. Common Stock AXNX Stock Holding History

CastleArk Alternatives’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-154,223
Closed -$10M – 313
2021
Q3 		$10M Buy
+154,223
New +$10.5M 0.38% 73

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

CastleArk Alternatives's AXNX Position: Q4 2021 in Review

CastleArk Alternatives sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2021, closing a stake of 154,223 shares — an estimated $10M sold.

CastleArk Alternatives first reported a position in AXNX in Q3 2021 and held it in 1 quarter. The position peaked at $10M in Q3 2021. 180 funds tracked by Wall St. Rank hold AXNX as of Q4 2021.

  • CastleArk Alternatives reported no remaining Axonics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • CastleArk Alternatives sold 154,223 Axonics, Inc. Common Stock shares in Q4 2021, an estimated $10M.
  • CastleArk Alternatives first reported a position in Axonics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • CastleArk Alternatives's Axonics, Inc. Common Stock position peaked at $10M in Q3 2021.
  • 180 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.